CAPLACIZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

ALX-0081

Preferred Name

English

CAPLACIZUMAB

Official Name

English

IMMUNOGLOBULIN, ANTI-(HUMAN VON WILLEBRAND'S BLOOD-COAGULATION FACTOR VIII DOMAIN A1) (HUMAN-LAMA GLAMA DIMERIC HEAVY CHAIN FRAGMENT PMP12A2H1)

Systematic Name

English

CAPLACIZUMAB [USAN]

Common Name

English

IMMUNOGLOBULIN VH-LINKER-VH FRAGMENT, ANTI-(HOMO SAPIENS VWF (VON WILLEBRAND FACTOR) A1 DOMAIN), HUMANIZED MONOCLONAL ANTIBODY VH-LINKER-VH CHAIN (1-259) (HUMANIZED VH (HOMO SAPIENS IGHV3-23*04 (82.5%) -(IGHD)-IGHJ4*01 L123>Q (123) (8.8.21) (1-128)) -TRI

Systematic Name

English

Caplacizumab [WHO-DD]

Common Name

English

caplacizumab [INN]

Common Name

English

CAPLACIZUMAB [MI]

Common Name

English

CAPLACIZUMAB [JAN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C1327

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

FDA ORPHAN DRUG

277909

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

WHO-ATC

B01AX07

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

Code System Code Type Description

INN

9511

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

PRIMARY

DRUG BANK

DB06081

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

PRIMARY

SMS_ID

100000166854

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

PRIMARY

CAS

915810-67-2

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

PRIMARY

LACTMED

Caplacizumab

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

PRIMARY

RXCUI

2110604

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

ALTERNATIVE

DAILYMED

2R27AB6766

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

PRIMARY

USAN

AB-28

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

PRIMARY

EVMPD

SUB181150

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

PRIMARY

WIKIPEDIA

Caplacizumab

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

PRIMARY

RXCUI

2110605

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

PRIMARY

ChEMBL

CHEMBL2109624

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

PRIMARY

MERCK INDEX

m12117

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

PRIMARY

DRUG CENTRAL

5308

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

PRIMARY

FDA UNII

2R27AB6766

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

PRIMARY

NCI_THESAURUS

C128625

Created by admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025

PRIMARY

ACTIVE MOIETY


					2R27AB6766